Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Glenhill Advisors Reduces Stake in Lionbridge Technologies Inc. (LIOX) by Selling 384,342 Shares

Glenhill Advisors, managed by Glenn J. Krevlin, has reduced its stake in Lionbridge Technologies Inc. (NASDAQ:LIOX). In a new filing with the U.S. Securities and Exchange Commission, Glenhill Advisors disclosed that it has sold 384,342 shares in a transaction last month at an average price of $6 apiece. Still, Glenhill Advisors holds 7.55 million shares of common stock of Lionbridge Technologies. The stake represents a decrease from 9.48 million shares the fund reported in its latest 13F filing.

Lionbridge Technologies, Inc. (NASDAQ:LIOX)

Lionbridge Technologies Inc. (NASDAQ:LIOX) provides translation, online marketing, global content management and application testing solutions, and has a market cap of $390.7 million. For the first quarter of 2014, the company reported a year-on-year increase of $6.5 million in revenue to $120.2 million, compared to $113.7 million in the same quarter of 2013. It also posted a $4.9 million increase in GAAP net income to $1.9 million, or $0.03 per share, compared to the first quarter of 2013, primarily due to strong year-on-year margin expansion in the company’s GLC segment.

Recently, Lionbridge Technologies Inc. (NASDAQ:LIOX) acquired Darwin Zone for a total estimated cash consideration of about $2.4 million. Darwin Zone is a full-service digital marketing services agency based in Costa Rica. Lionbridge believes that Darwin Zone’s 70 highly-skilled professionals in digital marketing campaign management, social media, search engine marketing and analytics, will enable it to add near-shore operations and expertise to support its growing digital marketing services offerings, according to a press release.

Other significant shareholders of Lionbridge Technologies Inc. (NASDAQ:LIOX) include Robert B. Gillam’s Mckinley Capital Management, which owns 980,860 shares and Jim Simons’ Renaissance Technologies, which holds 809,513 shares of the company.

Glenhill Advisors follows a long/short equity strategy, with a focus on small cap companies. As of the end of the first quarter of 2014, the value of the fund’s equity portfolio totaled $1.11 billion. Earlier, the fund disclosed increasing its position in Jamba Inc. (NASDAQ:JMBA) to 888,155 shares from 369,009 shares held earlier, the stake equals to 5.2% of the common stock.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!